Aleva Neurotherapeutics Scores CE Mark For Deep Brain Stimulation System
Executive Summary
Aleva Neurotherapeutics is taking its directSTIM deep brain stimulation system to the European market following receipt of CE mark. With a fresh round of financing under its belt, Aleva has its eyes on the US next.
You may also be interested in...
Directional Deep Brain Stim Firm Aleva Pumps Up In-House Commercial Expertise
Aleva Neurotherapeutics has made two senior management appointments as it prepares to take its first deep brain stimulation product to CE mark approval and to market.
Qiagen’s Ambitions: Standing Alone And Strengthening Infectious Disease Portfolio
Qiagen official Antoine Marchal outlines how NeuModx will strengthen its position in the infectious disease space.
Angle Files De Novo Submission For Parsortix System In Breast Cancer
The system has the potential to be the first FDA-cleared device for harvesting intact cancer cells from a blood sample for subsequent analysis.